The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Orthopedic Joint Cavity Viscoelastic Supplement Market Research Report 2024
Synopsis
Gel for Orthopedic Joint Injection is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.
Global Orthopedic Joint Cavity Viscoelastic Supplement market is projected to reach US$ 2329.4 million in 2029, increasing from US$ 1822 million in 2022, with the CAGR of 3.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Orthopedic Joint Cavity Viscoelastic Supplement market research.
Viscosupplementation involves the injection of hyaluronic acid-based solutions into the joints to relieve pain and improve mobility in patients with osteoarthritis. Factors driving market growth include the increasing prevalence of osteoarthritis, growing aging population, and the effectiveness of viscosupplementation in managing symptoms. The market is highly competitive, with several manufacturers offering viscosupplementation devices. However, challenges such as limited insurance coverage, high treatment costs, and the availability of alternative therapies may hinder market expansion. Nonetheless, the viscosupplementation devices market holds promising opportunities, driven by the rising demand for non-surgical treatment options for osteoarthritis and ongoing research and development efforts to enhance the efficacy of viscosupplementation products.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Orthopedic Joint Cavity Viscoelastic Supplement market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
Haohai Biological
Shanghai Jingfeng
Segment by Type
Single Injection
Three Injection
Five Injection
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Orthopedic Joint Cavity Viscoelastic Supplement report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Gel for Orthopedic Joint Injection is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.
Global Orthopedic Joint Cavity Viscoelastic Supplement market is projected to reach US$ 2329.4 million in 2029, increasing from US$ 1822 million in 2022, with the CAGR of 3.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Orthopedic Joint Cavity Viscoelastic Supplement market research.
Viscosupplementation involves the injection of hyaluronic acid-based solutions into the joints to relieve pain and improve mobility in patients with osteoarthritis. Factors driving market growth include the increasing prevalence of osteoarthritis, growing aging population, and the effectiveness of viscosupplementation in managing symptoms. The market is highly competitive, with several manufacturers offering viscosupplementation devices. However, challenges such as limited insurance coverage, high treatment costs, and the availability of alternative therapies may hinder market expansion. Nonetheless, the viscosupplementation devices market holds promising opportunities, driven by the rising demand for non-surgical treatment options for osteoarthritis and ongoing research and development efforts to enhance the efficacy of viscosupplementation products.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Orthopedic Joint Cavity Viscoelastic Supplement market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Sanofi
Anika Therapeutics
Seikagaku
Zimmer Biomet
Bioventus
Ferring
LG Chem
Freda
Haohai Biological
Shanghai Jingfeng
Segment by Type
Single Injection
Three Injection
Five Injection
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Orthopedic Joint Cavity Viscoelastic Supplement report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Orthopedic Joint Cavity Viscoelastic Supplement Market Overview
1.1 Product Overview and Scope of Orthopedic Joint Cavity Viscoelastic Supplement
1.2 Orthopedic Joint Cavity Viscoelastic Supplement Segment by Type
1.2.1 Global Orthopedic Joint Cavity Viscoelastic Supplement Market Value Comparison by Type (2023-2029)
1.2.2 Single Injection
1.2.3 Three Injection
1.2.4 Five Injection
1.3 Orthopedic Joint Cavity Viscoelastic Supplement Segment by Application
1.3.1 Global Orthopedic Joint Cavity Viscoelastic Supplement Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Orthopedic Joint Cavity Viscoelastic Supplement Market Size Estimates and Forecasts
1.4.1 Global Orthopedic Joint Cavity Viscoelastic Supplement Revenue 2018-2029
1.4.2 Global Orthopedic Joint Cavity Viscoelastic Supplement Sales 2018-2029
1.4.3 Global Orthopedic Joint Cavity Viscoelastic Supplement Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Orthopedic Joint Cavity Viscoelastic Supplement Market Competition by Manufacturers
2.1 Global Orthopedic Joint Cavity Viscoelastic Supplement Sales Market Share by Manufacturers (2018-2023)
2.2 Global Orthopedic Joint Cavity Viscoelastic Supplement Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Orthopedic Joint Cavity Viscoelastic Supplement Average Price by Manufacturers (2018-2023)
2.4 Global Orthopedic Joint Cavity Viscoelastic Supplement Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Orthopedic Joint Cavity Viscoelastic Supplement, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Orthopedic Joint Cavity Viscoelastic Supplement, Product Type & Application
2.7 Orthopedic Joint Cavity Viscoelastic Supplement Market Competitive Situation and Trends
2.7.1 Orthopedic Joint Cavity Viscoelastic Supplement Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Orthopedic Joint Cavity Viscoelastic Supplement Players Market Share by Revenue
2.7.3 Global Orthopedic Joint Cavity Viscoelastic Supplement Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Orthopedic Joint Cavity Viscoelastic Supplement Retrospective Market Scenario by Region
3.1 Global Orthopedic Joint Cavity Viscoelastic Supplement Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Orthopedic Joint Cavity Viscoelastic Supplement Global Orthopedic Joint Cavity Viscoelastic Supplement Sales by Region: 2018-2029
3.2.1 Global Orthopedic Joint Cavity Viscoelastic Supplement Sales by Region: 2018-2023
3.2.2 Global Orthopedic Joint Cavity Viscoelastic Supplement Sales by Region: 2024-2029
3.3 Global Orthopedic Joint Cavity Viscoelastic Supplement Global Orthopedic Joint Cavity Viscoelastic Supplement Revenue by Region: 2018-2029
3.3.1 Global Orthopedic Joint Cavity Viscoelastic Supplement Revenue by Region: 2018-2023
3.3.2 Global Orthopedic Joint Cavity Viscoelastic Supplement Revenue by Region: 2024-2029
3.4 North America Orthopedic Joint Cavity Viscoelastic Supplement Market Facts & Figures by Country
3.4.1 North America Orthopedic Joint Cavity Viscoelastic Supplement Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Orthopedic Joint Cavity Viscoelastic Supplement Sales by Country (2018-2029)
3.4.3 North America Orthopedic Joint Cavity Viscoelastic Supplement Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Orthopedic Joint Cavity Viscoelastic Supplement Market Facts & Figures by Country
3.5.1 Europe Orthopedic Joint Cavity Viscoelastic Supplement Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Orthopedic Joint Cavity Viscoelastic Supplement Sales by Country (2018-2029)
3.5.3 Europe Orthopedic Joint Cavity Viscoelastic Supplement Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Orthopedic Joint Cavity Viscoelastic Supplement Market Facts & Figures by Country
3.6.1 Asia Pacific Orthopedic Joint Cavity Viscoelastic Supplement Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Orthopedic Joint Cavity Viscoelastic Supplement Sales by Country (2018-2029)
3.6.3 Asia Pacific Orthopedic Joint Cavity Viscoelastic Supplement Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Orthopedic Joint Cavity Viscoelastic Supplement Market Facts & Figures by Country
3.7.1 Latin America Orthopedic Joint Cavity Viscoelastic Supplement Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Orthopedic Joint Cavity Viscoelastic Supplement Sales by Country (2018-2029)
3.7.3 Latin America Orthopedic Joint Cavity Viscoelastic Supplement Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Orthopedic Joint Cavity Viscoelastic Supplement Market Facts & Figures by Country
3.8.1 Middle East and Africa Orthopedic Joint Cavity Viscoelastic Supplement Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Orthopedic Joint Cavity Viscoelastic Supplement Sales by Country (2018-2029)
3.8.3 Middle East and Africa Orthopedic Joint Cavity Viscoelastic Supplement Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Orthopedic Joint Cavity Viscoelastic Supplement Sales by Type (2018-2029)
4.1.1 Global Orthopedic Joint Cavity Viscoelastic Supplement Sales by Type (2018-2023)
4.1.2 Global Orthopedic Joint Cavity Viscoelastic Supplement Sales by Type (2024-2029)
4.1.3 Global Orthopedic Joint Cavity Viscoelastic Supplement Sales Market Share by Type (2018-2029)
4.2 Global Orthopedic Joint Cavity Viscoelastic Supplement Revenue by Type (2018-2029)
4.2.1 Global Orthopedic Joint Cavity Viscoelastic Supplement Revenue by Type (2018-2023)
4.2.2 Global Orthopedic Joint Cavity Viscoelastic Supplement Revenue by Type (2024-2029)
4.2.3 Global Orthopedic Joint Cavity Viscoelastic Supplement Revenue Market Share by Type (2018-2029)
4.3 Global Orthopedic Joint Cavity Viscoelastic Supplement Price by Type (2018-2029)
5 Segment by Application
5.1 Global Orthopedic Joint Cavity Viscoelastic Supplement Sales by Application (2018-2029)
5.1.1 Global Orthopedic Joint Cavity Viscoelastic Supplement Sales by Application (2018-2023)
5.1.2 Global Orthopedic Joint Cavity Viscoelastic Supplement Sales by Application (2024-2029)
5.1.3 Global Orthopedic Joint Cavity Viscoelastic Supplement Sales Market Share by Application (2018-2029)
5.2 Global Orthopedic Joint Cavity Viscoelastic Supplement Revenue by Application (2018-2029)
5.2.1 Global Orthopedic Joint Cavity Viscoelastic Supplement Revenue by Application (2018-2023)
5.2.2 Global Orthopedic Joint Cavity Viscoelastic Supplement Revenue by Application (2024-2029)
5.2.3 Global Orthopedic Joint Cavity Viscoelastic Supplement Revenue Market Share by Application (2018-2029)
5.3 Global Orthopedic Joint Cavity Viscoelastic Supplement Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Orthopedic Joint Cavity Viscoelastic Supplement Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Sanofi Orthopedic Joint Cavity Viscoelastic Supplement Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Anika Therapeutics
6.2.1 Anika Therapeutics Corporation Information
6.2.2 Anika Therapeutics Description and Business Overview
6.2.3 Anika Therapeutics Orthopedic Joint Cavity Viscoelastic Supplement Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Anika Therapeutics Orthopedic Joint Cavity Viscoelastic Supplement Product Portfolio
6.2.5 Anika Therapeutics Recent Developments/Updates
6.3 Seikagaku
6.3.1 Seikagaku Corporation Information
6.3.2 Seikagaku Description and Business Overview
6.3.3 Seikagaku Orthopedic Joint Cavity Viscoelastic Supplement Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Seikagaku Orthopedic Joint Cavity Viscoelastic Supplement Product Portfolio
6.3.5 Seikagaku Recent Developments/Updates
6.4 Zimmer Biomet
6.4.1 Zimmer Biomet Corporation Information
6.4.2 Zimmer Biomet Description and Business Overview
6.4.3 Zimmer Biomet Orthopedic Joint Cavity Viscoelastic Supplement Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Zimmer Biomet Orthopedic Joint Cavity Viscoelastic Supplement Product Portfolio
6.4.5 Zimmer Biomet Recent Developments/Updates
6.5 Bioventus
6.5.1 Bioventus Corporation Information
6.5.2 Bioventus Description and Business Overview
6.5.3 Bioventus Orthopedic Joint Cavity Viscoelastic Supplement Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Bioventus Orthopedic Joint Cavity Viscoelastic Supplement Product Portfolio
6.5.5 Bioventus Recent Developments/Updates
6.6 Ferring
6.6.1 Ferring Corporation Information
6.6.2 Ferring Description and Business Overview
6.6.3 Ferring Orthopedic Joint Cavity Viscoelastic Supplement Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Ferring Orthopedic Joint Cavity Viscoelastic Supplement Product Portfolio
6.6.5 Ferring Recent Developments/Updates
6.7 LG Chem
6.6.1 LG Chem Corporation Information
6.6.2 LG Chem Description and Business Overview
6.6.3 LG Chem Orthopedic Joint Cavity Viscoelastic Supplement Sales, Revenue and Gross Margin (2018-2023)
6.4.4 LG Chem Orthopedic Joint Cavity Viscoelastic Supplement Product Portfolio
6.7.5 LG Chem Recent Developments/Updates
6.8 Freda
6.8.1 Freda Corporation Information
6.8.2 Freda Description and Business Overview
6.8.3 Freda Orthopedic Joint Cavity Viscoelastic Supplement Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Freda Orthopedic Joint Cavity Viscoelastic Supplement Product Portfolio
6.8.5 Freda Recent Developments/Updates
6.9 Haohai Biological
6.9.1 Haohai Biological Corporation Information
6.9.2 Haohai Biological Description and Business Overview
6.9.3 Haohai Biological Orthopedic Joint Cavity Viscoelastic Supplement Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Haohai Biological Orthopedic Joint Cavity Viscoelastic Supplement Product Portfolio
6.9.5 Haohai Biological Recent Developments/Updates
6.10 Shanghai Jingfeng
6.10.1 Shanghai Jingfeng Corporation Information
6.10.2 Shanghai Jingfeng Description and Business Overview
6.10.3 Shanghai Jingfeng Orthopedic Joint Cavity Viscoelastic Supplement Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Shanghai Jingfeng Orthopedic Joint Cavity Viscoelastic Supplement Product Portfolio
6.10.5 Shanghai Jingfeng Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Orthopedic Joint Cavity Viscoelastic Supplement Industry Chain Analysis
7.2 Orthopedic Joint Cavity Viscoelastic Supplement Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Orthopedic Joint Cavity Viscoelastic Supplement Production Mode & Process
7.4 Orthopedic Joint Cavity Viscoelastic Supplement Sales and Marketing
7.4.1 Orthopedic Joint Cavity Viscoelastic Supplement Sales Channels
7.4.2 Orthopedic Joint Cavity Viscoelastic Supplement Distributors
7.5 Orthopedic Joint Cavity Viscoelastic Supplement Customers
8 Orthopedic Joint Cavity Viscoelastic Supplement Market Dynamics
8.1 Orthopedic Joint Cavity Viscoelastic Supplement Industry Trends
8.2 Orthopedic Joint Cavity Viscoelastic Supplement Market Drivers
8.3 Orthopedic Joint Cavity Viscoelastic Supplement Market Challenges
8.4 Orthopedic Joint Cavity Viscoelastic Supplement Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
